LOWELL, Ark., Dec. 2, 2025 /PRNewswire/ — A paper published in Metabolites on Oct. 17, 2025, aimed to demonstrate that The Farmer’s Dog’s “fresh, human-grade” dog food provides superior health benefits for senior dogs compared to kibble. While the study’s premise appeared promising, expert analysis by BSM Partners reveals critical scientific and methodological failures that render its conclusions unreliable.
Beneath the surface lie fundamental design flaws, significant data inaccuracies, and major omissions that call the study’s integrity into question, including:
Peer-Reviewed Doesn’t Mean Proven
Peer review plays an important role in maintaining scientific standards, but it is not a guarantee of research quality or reliability. Flawed studies can and do make it into print, and when they do, their findings often ripple far beyond the scientific community. That’s why it’s essential for both pet owners and industry professionals to evaluate research critically and seek context beyond media headlines.
BSM Partners remains committed to transparent, scientifically supported research. We appreciate The Farmer’s Dog and all other pet food companies who have undertaken peer-reviewed research publications for the betterment of pets and their people. However, it’s critically important that research is accurate and methodologically sound, and the study in question does not clear that bar.
Ultimately, trust in pet nutrition depends on transparency, rigor, and reproducibility—not marketing spin. Sound science is the foundation of good nutrition, and our pets deserve nothing less.
Read more about the flaws found in the study here.
About BSM Partners
BSM Partners is the largest full-service pet care research, consulting, and strategy-to-shelf product innovation firm. BSM Partners’ research professionals collaborate with hundreds of clients ranging from the largest companies to the smallest upstart companies to formulate, review and advise on the development of thousands of new products annually. To learn more, go to www.bsmpartners.net.
SOURCE BSM Partners
TGA approval enables regional launch of Owlet’s clinically validated, award-winning infant health monitor; Owlet360™ subscription…
Concludes Distribution Agreement with Gore® for VIABIL® in the United States and Canada, Effective January…
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company…
BOSTON, Dec. 05, 2025 (GLOBE NEWSWIRE) -- A recent setback due to unexpected safety concern…
—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard…
Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the…